Sanjay Surana
Sanjay Surana is the managing director at Maxwell Life Science Private Ltd, a pharmaceutical company based in Boisar, India. He recently made headlines in connection with the Food and Drug Administration's findings regarding the manufacturing and exportation of a now-banned drug combination that has been linked to the opioid crisis in West African countries. Surana stated that while the company had explored the market for the drug, they had never proceeded with manufacturing or exporting it, citing a lack of buyers and the subsequent revocation of product permission.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| India | 1 | 6.00 | 0.02% | +0% | 1,380,004,385 | 239,003 | $2,900,000 | 502$ |
| Totals | 1 | 1,380,004,385 | 239,003 | $2,900,000 | 502$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
India:
Sanjay Surana, managing director at Maxwell Life Science, stated that while they had explored the market, they had never proceeded with manufacturing or exporting the drug.
6